Blauvelt, A., Papp, K. A., Merola, J. F., Gottlieb, A. B., Cross, N., Madden, C., Peterson, L., Cioffi, C., & Griffiths, C. E. (2019). Bimekizumab provides rapid and sustained improvements in scalp and nail outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized, double blinded, Phase 2b extension study. SKIN The Journal of Cutaneous Medicine, 3, S34.